Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in
Advertisement

Keros Therapeutics, Inc. KROS

Set alert

Price alert · KROS

All alert types
11.04 USD 0.00 0.00%

At close

10.90 -0.14 -1.27%

Pre-market · Nov 2, 8:20 AM ET

Bid
10.98 × 2
Ask
11.05 × 2
10.98 Day range 11.49
9.69 52-week range 22.55
YTD
-45.78%
1 year
-26.55%
Open
11.36
Prev close
11.04
Mkt cap
218.89M
Vol
120.16K
Avg vol
188.77K
EPS
-3.22
P/E
0.00
Div yield
0.00%
More statistics
Low
10.98
High
11.49
Forward P/E
-3.00
Beta
1.24
Short ratio
5.28
Inst. own
100.86%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
55.00
200-d avg
53.85
1y target
43.55

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for KROS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $2.17MExpenses → Gross Loss: $36.00KExpenses → Selling, General & Admin: $10.15MExpenses → Research & Development: $16.10MOther Operating Income → Expenses: $403.00KNet Loss → Expenses: $23.71MRevenue → Cost of Revenue: $367.00KOther Income$2.17MOther Operating Income$403.00KNet Loss$23.71MCost of Revenue$403.00KExpenses$26.28MGross Loss$36.00KSelling, General & Admin$10.15MResearch & Development$16.10MRevenue$367.00K

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

How to read it
KROS quarterly income statement
30.94M
22.33M
8.61M
-30.94M
-28.71M
-28.71M
-28.71M
-28.71M
-1.45
-1.45
-1.45
-28.71M
-28.71M
19.80M
19.80M

Balance sheet

How to read it
KROS quarterly balance sheet
259.06M
259.06M
266.88M
19.27M
287.60M
2.60M
15.72M
12.15M
13.13M
25.28M
-534.18M
262.32M
262.32M
20.72M
15.72M
13.13M
1.82M
2.25M

Cash flow

How to read it
KROS quarterly cash flow
1.05M
-3.31M
-23.89M
-155.00K
23.00K
-155.00K
-20.42M
5.38M
Advertisement